Medicare Part D – Page 37 – medicarereport.org

Friday, September 11, 2026

Latest:

CMS Medicare - General Part D/Prescription Drugs

Eileen Cook July 6, 2023July 6, 2023 CMS, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Revised Guidance

CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program

(Source - www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered

CDC Part D/Prescription Drugs

Eileen Cook June 22, 2023June 22, 2023 CDC, Medicare Part D, RSV, Vaccines

CDC advisory panel recommends seniors ‘may’ get RSV vaccine

(By Helen Branswell for ST A T) A panel of experts that advises the Centers for Disease Control and Prevention

CMS Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook June 12, 2023June 12, 2023 CMS, Medicaid, medicare, Medicare Part D, weight loss drugs

Weight loss drugs and CMS coverage: Why all eyes are on Medicare

(By Rylee Wilson for Becker’s Hospital Review ) New GLP-1 drugs to treat diabetes and obesity can be expensive, and

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook June 8, 2023June 8, 2023 Aging Population, CMS, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults

The Facts About Medicare Spending

(Source - The Kaiser Family Foundation Published June 2023) Medicare provides health insurance coverage for more than 65 million people,

Health Care Finance Health Insurance Part D/Prescription Drugs

Eileen Cook May 31, 2023May 31, 2023 Commercial Health Insuranxe, Healthcare Costs, Medicare Part D, Ultra-expensive drugs

Commercial insurance enrollees pay less for ultra-expensive drugs than Medicare Part D members: Study

(By Rylee Wilson for Becker’s Hospital Review ) Medicare Part D beneficiaries that don’t receive low-income subsidies spend 2.5 times

CMS Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook May 2, 2023May 2, 2023 CMS, medicare, Medicare Advantage, Medicare Part D

Half of All Eligible Medicare Beneficiaries Are Now Enrolled in Private Medicare Advantage Plans

(By Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation published May 01, 2023) According

Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook May 1, 2023May 1, 2023 Healthcare Costs, Medicare Advantage, Medicare Part D

More enrollees choosing higher-premium Medicare Advantage, Part D plans

(Rylee Wilson for Becker’s Hospital Review ) The average premium cost for Medicare Advantage plans sold on eHealth increased from

CMS Health Care Finance Health Care Redesign Legislative Update Medicare - General Part D/Prescription Drugs

Eileen Cook April 21, 2023April 21, 2023 CMS, Healthcare Finance, Inflation Reduction Act of 2022, medicare, Medicare Drug Price Negotiation Program, Medicare Part D

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

(By Juliette Cubanski for Kaiser Family Foundation Published: Apr 20, 2023) The Inflation Reduction Act of 2022 (the Act), signed

Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook April 19, 2023April 19, 2023 medicare, Medicare Drug Price Negotiation Program, Medicare Part D

Most drugs likely to be selected for Medicare price negotiation have low therapeutic benefit, study finds

(By Rylee Wilson for Becker’s Hospital Review ) Seven of the 10 drugs most likely to be selected for Medicare

Legal Actions/Court Decisions Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook April 17, 2023April 17, 2023 Fraud and Abuse, Medicaid, medicare, Medicare Part D, Supreme Court

Supreme Court looks at whether Medicare and Medicaid were overbilled under fraud law

(By Nina Totenberg for NPR) The U.S. Supreme Court will hear arguments on Tuesday in a case that could undermine